Influvac Tetra | The Australian Immunisation Handbook

On 10 April 2022 the Australian Government assumed a caretaker role. The Government is now operating in accordance with the Caretaker Conventions, pending the outcome of the 2022 federal election. See Information on Caretaker Conventions. On 10 April 2022 the Australian Government assumed a caretaker role. The Government is now operating in accordance with the Caretaker Conventions, pending the outcome of the 2022 federal election. See Information on Caretaker Conventions.

Sponsor:

Viatris Pty Ltd

Administration route:

Intramuscular injection, Subcutaneous injection

Vaccine group:

All people aged ≥6 months

Registered for use in people aged ≥6 months.

Quadrivalent inactivated influenza vaccine

Each 0.5 mL monodose pre-filled syringe contains:

15 µg haemagglutinin of each of the 4 recommended influenza virus strains
≤100 ng ovalbumin
≤0.01 mg formaldehyde
0.02 mg cetrimonium bromide
1 mg sodium citrate
0.2 mg sucrose
1 ng gentamicin sulfate

May contain traces of:

tylosine tartrate
hydrocortisone
polysorbate 80

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated:

21 April 2022

Last reviewed:

21 April 2022

Is there anything wrong with this page?

Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/influvac-tetra.